Why is the Implementation of Beta-Lactam Therapeutic Drug Monitoring for the Critically Ill Falling Short? A Multicenter Mixed-Methods Study

Erin F. Barreto,Pooja N. Chitre,Kathleen H. Pine,Kathryn K. Shepel,Andrew D. Rule,Mohammad H. Alshaer,Mohd Hafiz Abdul Aziz,Jason A. Roberts,Marc H. Scheetz,Sara E. Ausman,Lindsay N. Moreland-Head,Christina G. Rivera,Paul J. Jannetto,Kristin C. Mara,Kasey R. Boehmer

Therapeutic Drug Monitoring（2023）

引用 1|浏览32

暂无评分

摘要

Broad enthusiasm for BL TDM among participants was found. Prior literature suggested that assay availability was the primary barrier to implementation; however, the data revealed many more individual and organizational attributes, which impacted the BL TDM implementation. Internalization should particularly be focused on to improve the adoption of this evidence-based practice.

查看译文

关键词

critically ill,drug,beta-lactam,mixed-methods

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要